Mathematical modeling and experimental testing of three bioreactor configurations based on windkessel models
Abstract
Overview
This paper presents an experimental study
of three bioreactor configurations. The bioreactor
is intended to be used for the development
of tissue-engineered heart valve substitutes.
Therefore it must be able to reproduce
physiological flow and pressure waveforms
accurately. A detailed analysis of three bioreactor
arrangements is presented using mathematical
models based on the windkessel (WK)
approach. First, a review of the many applications
of this approach in medical studies
enhances its fundamental nature and its usefulness.
Then the models are developed with
reference to the actual components of the
bioreactor. This study emphasizes different
conflicting issues arising in the design
process of a bioreactor for biomedical purposes,
where an optimization process is essential to reach a compromise satisfying all conditions.
Two important aspects are the need for
a simple system providing ease of use and
long-term sterility, opposed to the need for an
advanced (thus more complex) architecture
capable of a more accurate reproduction of the
physiological environment. Three classic WK
architectures are analyzed, and experimental
results enhance the advantages and limitations
of each one.
Keywords
Bioreactor, design, heart valve, tissue engineering, windkessel models.
Article Information
Correspondence
Jean Ruel, 1026 avenue de la Médecine, Pavillon Pouliot, office 1361, Québec, PQ, GIV 0A6, Canada. E-mail: jruel@gmc.ulaval.ca
Acknowledgements
We wish to thank our great
team of collaborators, Yvan Maciel, professor at
Laval University’s Department of Mechanical
Engineering, Dr François Auger and Dr Lucie
Germain, professors at Laval University’s
Department of Surgery, and Dan Lacroix, project
manager at the LOEX research center (St-
Sacrement Hospital) in Quebec. We also wish to
thank Guillaume Lalande, Rosalie Pelletier, and
Catherine Tremblay, M.Sc. students, for their
support and contribution to this work.
Received
2009-06-22
Further Resources
Trending Topic
After decades of debate, patent foramen ovale (PFO) closure is now a well-established strategy to reduce recurrent stroke in patients aged 18–60 years who have had a PFO-associated stroke.1 Patients who underwent PFO closure continue to have a higher stroke risk than the general population. A recent study demonstrated a 2.1% higher stroke rate in the […]
After decades of debate, patent foramen ovale (PFO) closure is now a well-established strategy to reduce recurrent stroke in patients aged 18–60 years who have had a PFO-associated stroke.1 Patients who underwent PFO closure continue to have a higher stroke risk ...
Cardiovascular medicine continues to advance at a remarkable pace, driven by innovation, interdisciplinary collaboration and an ever-deepening understanding of disease mechanisms. As patient populations age and chronic conditions become increasingly complex, the field stands at the intersection of precision therapy, ...
Cardiovascular medicine stands at a pivotal crossroads—shaped by rapid advances in precision therapies, a deepening understanding of disease mechanisms, and an urgent imperative to address global health disparities. As the burden of cardiovascular disease continues to evolve, so too ...
Conduction system pacing (CSP) is being increasingly adopted as a more physiological alternative to right ventricular and biventricular pacing and is an integral part of the European Heart Rhythm Association (EHRA) core curriculum for the device specialist.1–6 Left bundle branch ...
Welcome to this issue of Heart International. As ever, we aim to provide our readers with the latest developments, insights, and evidence-based discussions in cardiovascular care. This edition is particularly poignant, as we begin with a heartfelt tribute to an ...
Forty-seven years ago, Andreas Gruentzig introduced ‘percutaneous transluminal coronary angioplasty’ (PTCA) as a new approach to treating symptomatic occlusive coronary artery disease.1 The mechanism of balloon angioplasty (BA) formed the foundation around which newer equipment and technologies were developed, including ...
Tricuspid regurgitation (TR) is a frequent finding on echocardiography, with detection rates reaching up to 86% across the different ranges of severity, with moderate or greater TR being reported in at least 6–8% of patients.1–3 The prevalence of TR increases with age, ...
Cardiovascular diseases are the most common cause of mortality and morbidity in adults worldwide.1Â Coronary angiography (CAG) is the gold standard method for evaluating atherosclerotic coronary artery disease (CAD).2Â It is conventionally performed via the trans-femoral (TF) route. Recently, however, ...
We are sorry to announce the death of one of our valued editorial board members, Dr Richard Heuser (November 17, 1950–May 23, 2024). Richard R Heuser, MD, FACC, FACP, FESC, MSCAI, was an internationally recognized cardiologist, inventor, educator and author, and was a ...
Welcome to the summer issue of Heart International. We are excited to present a collection of insightful articles that delve into various aspects of cardiovascular health and related interventions. This issue encompasses a wide array of topics, from novel treatment ...
Clinically relevant tricuspid regurgitation (TR) is a common disorder, affecting approximately 4% of people 75 years of age or older.1Â If left untreated, severe TR results in volume overload and right ventricular remodelling. This eventually leads to symptomatic right-sided heart failure, along ...
In this issue of Heart International, we are delighted to present a collection of insightful articles that encompass a wide spectrum of topics within the field of cardiovascular medicine. As we navigate the landscape of cardiovascular disease, heart failure, preventative ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
